Jeffrey Gudin - Jan 25, 2023 Form 4 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Chief Medical Officer, Director
Signature
/s/ Christopher Chipman, attorney-in-fact
Stock symbol
VRPX
Transactions as of
Jan 25, 2023
Transactions value $
$0
Form type
4
Date filed
1/27/2023, 07:30 PM
Previous filing
Feb 25, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +50K $0.00 50K Jan 25, 2023 Common Stock 50K $0.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in three equal annual installments commencing on January 25, 2024.